Synektik

Synektik Rule of 40

The Rule of 40 of Synektik (SNT.WA) as of Oct 31, 2026 is 32.21 %. In the previous year, Rule of 40 was 56.80 % — a change of -43.29% (lower).

Rule of 40

32.21 %

YoY

-43.29%

Last updated:

Rule of 40 of Synektik is 2025 32.21 % . Rule of 40 of Synektik was 2024 56.80 % . It decreases by -43.29% lower compared to the previous year.

The Synektik Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
78.39 PLN
Jan 1, 2019
37.41 PLN
Jan 1, 2020
2.62 PLN
Jan 1, 2021
11.28 PLN
Jan 1, 2022
33.94 PLN
Jan 1, 2023
183.00 PLN
Jan 1, 2024
56.80 PLN
Jan 1, 2025
32.21 PLN
The Synektik Rule of 40 history
YEARRule of 40YoY
32.21 %-43.29%
56.80 %-68.96%
183.00 %+439.14%
33.94 %+200.85%
11.28 %+330.43%
2.62 %-92.99%
37.41 %-52.28%
78.39 %+137.58%
33.00 %-190.24%
-36.56 %-758.54%
5.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Rule of 40 of Synektik is 32.21 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Synektik since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quality — Synektik

AAQSPiotroski F-ScoreAltman Z-ScoreGraham NumberRule of 40

All Key Metrics — Synektik